World Health Organization. Dementia facts. https://www.who.int/news-room/fact-sheets/detail/dementia. Accessed 13 Dec 2024.

Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413–46. https://doi.org/10.1016/S0140-6736(20)30367-6.

Article  PubMed  PubMed Central  Google Scholar 

Ghossein N KM, Lahkar AD. Anticholinergic medications. StatPearls Publishing. 2022. https://www.ncbi.nlm.nih.gov/books/NBK555893/.

Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia: a nested case-control study. JAMA Intern Med. 2019;179(8):1084–93. https://doi.org/10.1001/jamainternmed.2019.0677.

Article  PubMed  PubMed Central  Google Scholar 

Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175(3):401–7. https://doi.org/10.1001/jamainternmed.2014.7663.

Article  PubMed  PubMed Central  Google Scholar 

Gray SL, Hanlon JT. Anticholinergic medication use and dementia: latest evidence and clinical implications. Ther Adv Drug Saf. 2016;7(5):217–24.

Article  PubMed  PubMed Central  Google Scholar 

Risacher SL, McDonald BC, Tallman EF, et al. Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults. JAMA Neurol. 2016;73(6):721–32. https://doi.org/10.1001/jamaneurol.2016.0580.

Article  PubMed  PubMed Central  Google Scholar 

Perry EK, Kilford L, Lees AJ, Burn DJ, Perry RH. Increased Alzheimer pathology in Parkinson’s disease related to antimuscarinic drugs. Ann Neurol. 2003;54(2):235–8. https://doi.org/10.1002/ana.10639.

Article  CAS  PubMed  Google Scholar 

Wurtman RJ. How anticholinergic drugs might promote Alzheimer’s disease: more amyloid-β and less phosphatidylcholine. J Alzheimers Dis. 2015;46(4):983–7. https://doi.org/10.3233/jad-150290.

Article  CAS  PubMed  Google Scholar 

Richardson K, Fox C, Maidment I, et al. Anticholinergic drugs and risk of dementia: case-control study. BMJ. 2018;361: k1315. https://doi.org/10.1136/bmj.k1315.

Article  PubMed  PubMed Central  Google Scholar 

Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383(9920):911–22. https://doi.org/10.1016/s0140-6736(13)60688-1.

Article  PubMed  Google Scholar 

Pereira JV-B, Aung Thein MZ, Nitchingham A, Caplan GA. Delirium in older adults is associated with development of new dementia: a systematic review and meta-analysis. Int J Geriatr Psychiatry. 2021;36(7):993–1003. https://doi.org/10.1002/gps.5508.

Article  PubMed  Google Scholar 

Mohanty S, Lindroth H, Timsina L, et al. A mediation analysis examining high risk, anticholinergic medication use, delirium, and dementia after major surgery. J Surg Res. 2024;298:222–9. https://doi.org/10.1016/j.jss.2024.03.018.

Article  CAS  PubMed  Google Scholar 

Campanelli CM. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–31. https://doi.org/10.1111/j.1532-5415.2012.03923.x.

Article  PubMed Central  Google Scholar 

Indiana University Health. IU Health: about our system. https://iuhealth.org/about-our-system. Accessed 15 Feb 2024.

Regenstrief Institute. The Indiana Network for Patient Care. https://www.regenstrief.org/rds/data/. Accessed 15 Feb 2024.

Khuri SF, Henderson WG, Daley J, et al. Successful implementation of the Department of Veterans Affairs’ National Surgical Quality Improvement Program in the private sector: the Patient Safety in Surgery study. Ann Surg. 2008;248(2):329–36. https://doi.org/10.1097/SLA.0b013e3181823485.

Article  PubMed  Google Scholar 

Kind AJH, Buckingham WR. Making neighborhood-disadvantage metrics accessible—the neighborhood atlas. N Engl J Med. 2018;378(26):2456–8. https://doi.org/10.1056/NEJMp1802313.

Article  PubMed  PubMed Central  Google Scholar 

Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27. https://doi.org/10.1097/00005650-199801000-00004.

Article  CAS  PubMed  Google Scholar 

van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47(6):626–33. https://doi.org/10.1097/MLR.0b013e31819432e5.

Article  PubMed  Google Scholar 

Campbell N, Maidment I, Fox C, Khan B, Boustani M. The 2012 update to the anticholinergic cognitive burden scale. J Am Geriatr Soc. 2013;61(S1):S142–3.

Google Scholar 

Moura LMVR, Festa N, Price M, et al. Identifying Medicare beneficiaries with dementia. J Am Geriatr Soc. 2021;69(8):2240–51. https://doi.org/10.1111/jgs.17183.

Article  PubMed  PubMed Central  Google Scholar 

Howe CJ, Cole SR, Westreich DJ, Greenland S, Napravnik S, Eron JJ Jr. Splines for trend analysis and continuous confounder control. Epidemiology. 2011;22(6):874–5. https://doi.org/10.1097/EDE.0b013e31823029dd.

Article  PubMed  PubMed Central  Google Scholar 

A Package for Survival Analysis in R. R package version 3.5-7. 2023. https://CRAN.R-project.org/package=survival

Li R, Chambless L. Test for additive interaction in proportional hazards models. Ann Epidemiol. 2007;17(3):227–36. https://doi.org/10.1016/j.annepidem.2006.10.009.

Article  PubMed  Google Scholar 

VanderWeele TJ, Knol MJ. A tutorial on interaction. Epidemiol Methods. 2014;3(1):33–72. https://doi.org/10.1515/em-2013-0005.

Article  Google Scholar 

VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167(4):268–74. https://doi.org/10.7326/m16-2607.

Article  PubMed  Google Scholar 

Amieva H, Le Goff M, Millet X, et al. Prodromal Alzheimer’s disease: successive emergence of the clinical symptoms. Ann Neurol. 2008;64(5):492–8. https://doi.org/10.1002/ana.21509.

Article  PubMed  Google Scholar 

Jones E, Aigbogun MS, Pike J, Berry M, Houle CR, Husbands J. Agitation in dementia: real-world impact and burden on patients and the healthcare system. J Alzheimers Dis. 2021;83(1):89–101. https://doi.org/10.3233/jad-210105.

Article  PubMed  PubMed Central  Google Scholar 

Gallagher P, Curtin D, de Siún A, et al. Antipsychotic prescription amongst hospitalized patients with dementia. QJM. 2016;109(9):589–93. https://doi.org/10.1093/qjmed/hcw023.

Article  CAS  PubMed  Google Scholar 

Dmochowski RR, Thai S, Iglay K, et al. Increased risk of incident dementia following use of anticholinergic agents: a systematic literature review and meta-analysis. Neurourol Urodyn. 2021;40(1):28–37. https://doi.org/10.1002/nau.24536.

Article  PubMed  Google Scholar 

MacLeod SM, Giles HG, Bengert B, Liu FF, Sellers EM. Age- and gender-related differences in diazepam pharmacokinetics. J Clin Pharmacol. 1979;19(1):15–9. https://doi.org/10.1002/j.1552-4604.1979.tb01612.x.

Article  CAS  PubMed  Google Scholar 

Trenaman SC, Bowles SK, Andrew MK, Goralski K. The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs. Pharmacol Res Perspect. 2021;9(3): e00775. https://doi.org/10.1002/prp2.775.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bigos KL, Pollock BG, Coley KC, et al. Sex, race, and smoking impact olanzapine exposure. J Clin Pharmacol. 2008;48(2):157–65. https://doi.org/10.1177/0091270007310385.

Article  CAS  PubMed